Perspective Therapeutics, Inc. (CATX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 275.35M | 148.39M | 178.5M | 195.96M | 215.74M | 231.16M | 270.17M | 294.24M | 188.2M | 16.84M | 21.69M | 31.95M |
| Cash & Short-Term Investments | 270.93M | 144.74M | 174.14M | 191.58M | 211.7M | 226.92M | 267.85M | 292.87M | 180.65M | 9.24M | 17.98M | 28.32M |
| Cash Only | 53.97M | 30.63M | 26.76M | 28.85M | 44.41M | 61.58M | 226.44M | 252M | 142.12M | 9.24M | 17.98M | 28.32M |
| Short-Term Investments | 216.96M | 114.11M | 147.38M | 162.73M | 167.3M | 165.34M | 41.4M | 40.87M | 38.53M | 0 | 0 | 0 |
| Accounts Receivable | 58K | 6K | 179K | 225K | 78K | 1.48M | 217K | 142K | 999K | 1.18M | 1.73M | 1.11M |
| Days Sales Outstanding | 37.89 | - | 88.92 | 47.54 | - | - | - | - | - | 396.66 | 68.53 | 75.14 |
| Inventory | 0 | 0 | 0 | 0 | 0 | -1.37M | 0 | 0 | 0 | 0 | 1.01M | 1.09M |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | 66.98 | 61.87 |
| Other Current Assets | 4.37M | 3.65M | 4.18M | 4.16M | 3.96M | 1.45M | 2.11M | 1.23M | 6.55M | 5.36M | 961K | 1.43M |
| Total Non-Current Assets | 135.42M | 118.58M | 116.33M | 114.77M | 113.61M | 109.94M | 120.98M | 91.68M | 90.09M | 81.05M | 88.83M | 88.19M |
| Property, Plant & Equipment | 94.93M | 78.1M | 65.89M | 64.37M | 63.24M | 59.54M | 46.23M | 16.77M | 15.36M | 6.32M | 8.54M | 7.85M |
| Fixed Asset Turnover | 0.00x | - | 0.00x | 0.00x | - | - | - | - | - | 0.05x | 0.23x | 0.20x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 24.06M | 24.06M | 24.06M | 24.06M | 27.32M | 27.32M |
| Intangible Assets | 40M | 40M | 50M | 50M | 50M | 50.01M | 50M | 50M | 50M | 50.35M | 50M | 50M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 322K | 0 | 0 | 0 | 133K | 182K | 182K |
| Other Non-Current Assets | 490K | 486K | 438K | 401K | 366K | 72K | 694K | 854K | 664K | 182K | 2.79M | 2.84M |
| Total Assets | 410.77M | 266.97M | 294.82M | 310.73M | 329.35M | 341.1M | 391.15M | 385.92M | 278.29M | 97.89M | 110.52M | 120.14M |
| Asset Turnover | 0.00x | - | 0.00x | 0.00x | - | - | - | - | - | 0.00x | 0.02x | 0.01x |
| Asset Growth % | 24.72% | -21.73% | -24.63% | -19.48% | 18.35% | 248.45% | 253.93% | 221.21% | 118.02% | 67.98% | 76.72% | 86.45% |
| Total Current Liabilities | 31.49M | 28.68M | 20.62M | 12.99M | 12.68M | 18.23M | 28.14M | 10.61M | 14.5M | 15.66M | 8.12M | 8.59M |
| Accounts Payable | 0 | 0 | 12.95M | 7.05M | 8.73M | 10.34M | 21.81M | 6.13M | 6.03M | 6.91M | 3.87M | 4.91M |
| Days Payables Outstanding | - | - | 1.19K | 979.65 | - | - | - | - | - | - | 278.89 | 218.1 |
| Short-Term Debt | 1.07M | 623K | 55K | 54K | 53K | 52K | 51K | 54K | 50K | 49K | 48K | 71K |
| Deferred Revenue (Current) | 26.6M | 26.6M | 0 | 0 | 0 | 1.4M | 1.4M | 1.4M | 1.4M | 0 | 0 | 0 |
| Other Current Liabilities | 3.82M | 1.46M | 6.91M | 5.04M | 2.91M | 5.48M | 0 | 0 | 5.07M | 4.73M | 548K | 684K |
| Current Ratio | 8.75x | 5.17x | 8.66x | 15.09x | 17.02x | 12.68x | 9.60x | 27.73x | 12.98x | 1.07x | 2.67x | 3.72x |
| Quick Ratio | 8.75x | 5.17x | 8.66x | 15.09x | 17.02x | 12.76x | 9.60x | 27.73x | 12.98x | 1.07x | 2.55x | 3.59x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | -143.38 | -81.1 |
| Total Non-Current Liabilities | 31.84M | 31.26M | 31.99M | 32.05M | 32.02M | 32.2M | 34.54M | 34.31M | 33.89M | 7.05M | 3.63M | 2.9M |
| Long-Term Debt | 1.55M | 1M | 1.58M | 1.6M | 1.61M | 1.63M | 1.64M | 1.65M | 1.66M | 1.68M | 1.69M | 1.7M |
| Capital Lease Obligations | 0 | 0 | 971K | 1.07M | 1.17M | 1.43M | 1.68M | 1.45M | 1.04M | 780K | 1.28M | 543K |
| Deferred Tax Liabilities | 1.7M | 1.7M | 2.5M | 2.5M | 2.5M | 2.5M | 4.59M | 4.59M | 4.59M | 4.59M | 0 | 0 |
| Other Non-Current Liabilities | 28.59M | 28.55M | 342K | 284K | 145K | 55K | 33K | 19K | 0 | 0 | 668K | 659K |
| Total Liabilities | 63.33M | 59.94M | 52.61M | 45.03M | 44.7M | 50.43M | 62.68M | 44.92M | 48.4M | 22.71M | 11.75M | 11.49M |
| Total Debt | 2.62M | 1.63M | 3.31M | 3.57M | 3.82M | 4.06M | 4.27M | 3.88M | 2.88M | 2.55M | 3.31M | 2.58M |
| Net Debt | -51.35M | -29M | -23.45M | -25.28M | -40.59M | -57.52M | -222.18M | -248.13M | -139.24M | -6.69M | -14.68M | -25.74M |
| Debt / Equity | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.03x | 0.03x | 0.02x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -269.34x | -597.17x | -398.52x | -183.87x | -141.01x | -579.99x | -218.16x | -489.22x | -406.69x | -368.58x | -752.43x | -437.46x |
| Total Equity | 347.44M | 207.03M | 242.22M | 265.69M | 284.64M | 290.67M | 328.47M | 341M | 229.89M | 75.18M | 98.77M | 108.65M |
| Equity Growth % | 22.06% | -28.77% | -26.26% | -22.08% | 23.82% | 286.63% | 232.56% | 213.84% | 94.78% | 36.67% | 71.17% | 77.31% |
| Book Value per Share | 3.35 | 2.80 | 3.26 | 3.76 | 3.93 | 4.12 | 4.65 | 5.12 | 4.64 | 1.37 | 1.80 | 1.98 |
| Total Shareholders' Equity | 347.44M | 207.03M | 242.22M | 265.69M | 284.64M | 290.67M | 328.47M | 341M | 229.89M | 75.18M | 98.77M | 108.65M |
| Common Stock | 114K | 74K | 74K | 74K | 73K | 70K | 67K | 67K | 587K | 282K | 281K | 280K |
| Retained Earnings | -361.03M | -334.84M | -297.35M | -271.38M | -249.9M | -231.72M | -191.55M | -176.43M | -164.72M | -152.44M | -127.77M | -117.41M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Accumulated OCI | -226K | 110K | 114K | 3K | 19K | -51K | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |